Interferons Transcriptionally Up-Regulate MLKL Expression in Cancer Cells

Autor: Sjoerd J L van Wijk, Anne-Kathrin Knuth, Stefanie Rösler, Barbara Schenk, Lisa Kowald, Simone Fulda
Jazyk: angličtina
Rok vydání: 2019
Předmět:
0301 basic medicine
Cancer Research
NSA
necrosulfonamide

GAPDH
glyceraldehyde 3-phosphate dehydrogenase

0302 clinical medicine
Interferon
Neoplasms
AML
acute myeloid leukemia

Regulation of gene expression
Gene knockdown
ns
non-silencing

lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens
Cell biology
Gene Expression Regulation
Neoplastic

STAT
signal transducer and activator of transcription

STAT1 Transcription Factor
Caspases
030220 oncology & carcinogenesis
pSTAT1
phospho-STAT1

JAK
Janus kinase

medicine.drug
Transcriptional Activation
Original article
TNFα
tumor necrosis factor alpha

Biology
DSMZ
Deutsche Sammlung von Mikroorganismen und Zellkulturen

lcsh:RC254-282
PI
propidium iodide

03 medical and health sciences
Cell Line
Tumor

IRF1
IFN-regulatory factor 1

medicine
Humans
IFN
interferon

ddc:610
RNA
Messenger

RIPK
receptor-interacting protein kinase

MLKL
mixed-lineage kinase domain-like

Transcription factor
zVAD.fmk
N-benzyloxycarbonyl-Val-Ala-Asp-fluoromethylketone

FDA
Food and Drug Administration

MEF
mouse embryonic fibroblast

030104 developmental biology
IRF1
Cancer cell
STAT protein
ISG
IFN-stimulated gene

Interferons
FCS
fetal calf serum

Janus kinase
Protein Kinases
Interferon Regulatory Factor-1
Zdroj: Neoplasia: An International Journal for Oncology Research, Vol 21, Iss 1, Pp 74-81 (2019)
Neoplasia (New York, N.Y.)
ISSN: 1476-5586
Popis: Interferons (IFNs) are key players in the tumor immune response and act by inducing the expression of IFN-stimulated genes (ISGs). Here, we identify the mixed-lineage kinase domain-like pseudokinase (MLKL) as an ISG in various cancer cell lines. Both type I and type II IFNs increase the expression of MLKL indicating that MLKL up-regulation is a general feature of IFN signaling. IFNγ up-regulates mRNA as well as protein levels of MLKL demonstrating that IFNγ transcriptionally regulates MLKL. This notion is further supported by Actinomycin D chase experiments showing that IFNγ-stimulated up-regulation of MLKL is prevented in the presence of the transcriptional inhibitor Actinomycin D. Also, knockdown of the transcription factor IFN-regulatory factor 1 (IRF1) and signal transducer and activator of transcription (STAT) 1 as well as knockout of IRF1 significantly attenuate IFNγ-mediated induction of MLKL mRNA levels. Up-regulation of MLKL by IFNγ provides a valuable tool to sensitize cells towards necroptotic cell death and to overcome apoptosis resistance of cancer cells.
Databáze: OpenAIRE